...
首页> 外文期刊>Thoracic cancer. >Prognostic impact of micropapillary component in patients with node‐negative subcentimeter lung adenocarcinoma: A Chinese cohort study
【24h】

Prognostic impact of micropapillary component in patients with node‐negative subcentimeter lung adenocarcinoma: A Chinese cohort study

机译:微小足体组分对节点阴性患者肺腺癌患者的预后影响:中国队列研究

获取原文

摘要

Background In this study, we investigated the prognostic significance of a micropapillary (MP) component in patients with subcentimeter lung adenocarcinoma. Methods A total of 311 patients with subcentimeter lung adenocarcinoma who underwent surgical resection between January 2009 to December 2012 from seven medical centers were included. Recurrence‐free survival (RFS) and overall survival (OS) were analyzed. Results The five‐year RFS was 79.8% in 97 (97/311, 31%) cases of adenocarcinoma with a MP component and 93.5% in the 214 (214/311, 69%) cases without. In multivariate analysis, MP was an independent risk factor for worse RFS (hazard ratio [HR], 3.73; 95% confidence interval [CI]: 1.87–7.42; P ?0.001) and OS (HR, 5.84; 95% CI: 2.20–15.49; P ?0.001). There was no significant difference among wedge resection, segmentectomy and lobectomy on RFS ( P = 0.256) and OS ( P = 0.103) in patients without MP. Regarding patients with a MP component, lobectomy achieved equivalent prognosis than segmentectomy, and both were better than wedge resection ( P = 0.001). Conclusions A MP component still suggest a poor prognosis in subcentimeter lung adenocarcinoma. Patients with subcentimeter lung adenocarcinoma with a MP component of 5% or greater treated with wedge resection were at higher risk of recurrence than patients treated with anatomical resection.
机译:背景技术在本研究中,我们研究了患有患者肺腺癌患者患者的微杂皮虫(MP)组分的预后意义。方法共纳入2009年1月至2012年12月七月至2012年12月间接受手术切除的311例患有311例患有七月的肺癌。分析了无复发存活(RFS)和总存活(OS)。结果97例(97/311,31%)腺癌的五年射频为79.8%,214例(214/311,69%)患者腺癌的腺癌和93.5%。在多变量分析中,MP是RFS更差的独立危险因素(危险比[HR],3.73; 95%置信区间[CI]:1.87-7.42; P <0.001)和OS(HR,5.84; 95%CI: 2.20-15.49; p <0.001)。在没有MP的患者中,RFS(p = 0.256)和OS(p = 0.256)和OS(p = 0.103)中的楔形切除,分段切除术和肺切除术中没有显着差异。关于患有MP组分的患者,LOBECTOMY达到了相同的预后,而不是分段切除术,两者都优于楔切除(P = 0.001)。结论MP组分仍然表明患有肺腺癌的预后差。具有楔形切除术治疗5%或更大的MP组分的患者的肺腺癌患者比用解剖切除治疗的患者更高的复发风险。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号